Dexycu is a Intraocular Injection, Suspension in the Human Prescription Drug category. It is labeled and distributed by Eyepoint Pharmaceuticals Us, Inc. The primary component is Dexamethasone.
| Product ID | 71879-001_60524f04-13ae-4b19-8da0-41d141f7b574 |
| NDC | 71879-001 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dexycu |
| Generic Name | Dexamethasone |
| Dosage Form | Injection, Suspension |
| Route of Administration | INTRAOCULAR |
| Marketing Start Date | 2018-05-22 |
| Marketing Category | NDA / NDA |
| Application Number | NDA208912 |
| Labeler Name | EyePoint Pharmaceuticals US, Inc |
| Substance Name | DEXAMETHASONE |
| Active Ingredient Strength | 517 ug/.005mL |
| Pharm Classes | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2018-05-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA208912 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-03-11 |
| Ingredient | Strength |
|---|---|
| DEXAMETHASONE | 517 ug/.005mL |
| SPL SET ID: | 583d70ed-bc42-465b-983d-c770db58406f |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 71879-001 | Dexycu | Dexycu |
| 0054-3177 | Dexamethasone | Dexamethasone |
| 0054-4179 | Dexamethasone | Dexamethasone |
| 0054-4180 | Dexamethasone | Dexamethasone |
| 0054-4181 | Dexamethasone | Dexamethasone |
| 0054-4182 | Dexamethasone | Dexamethasone |
| 0054-4183 | Dexamethasone | Dexamethasone |
| 0054-4184 | Dexamethasone | Dexamethasone |
| 0054-4186 | Dexamethasone | Dexamethasone |
| 0054-8174 | Dexamethasone | Dexamethasone |
| 0023-3348 | OZURDEX | dexamethasone |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DEXYCU 86725761 5734181 Live/Registered |
Icon Bioscience, Inc. 2015-08-14 |